P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients.

autologous formalin-fixed tumor vaccine - Cell-Medicine

http://www.ncbi.nlm.nih.gov/pubmed/37484760

Eiichi Ishikawa; Erika Yamada; Hidehiro Kohzuki; Masahide Matsuda; Narushi Sugii; Noriaki Sakamoto; Shinya Watanabe; Shunichiro Miki; Takao Tsurubuchi; Tsubasa Miyazaki

Jul 24, 2023